Tag Archives: Servier Pharmaceutical Co Ltd

Almitrine-Raubasine Combination (Duxil) for Dementia

Abstract This systematic review investigated almitrine-raubasine combination (brand name Duxil) as an alternative treatment for dementia. There was insufficient evidence to support the routine use of Duxil for the treatment of patients with dementia, due to the low methodological quality … Continue reading

Posted in For Researchers (mostly), International, Pharmacological Treatments, Systematic Reviews, Universal Interest | Tagged , , | Leave a comment